English

Protea Biosciences Group, Inc.

EDGAR

PRGB Registration statement (S-1) · filed 2017-08-29

56 filing records in this dataset, filed from 2005-11-09 to 2017-08-29. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

328 thousand USD

2017 Q2 · USD

Exact inputs and evidence

Revenue: 328092 USD Source

Operating margin

-417.7%

2017 Q2 · %

Exact inputs and evidence

Operating Income: -1370452 USD Source
Revenue: 328092 USD Source

Operating cash flow

-1.44 million USD

2017 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -2270549 USD Source
Operating Cash Flow: -834458 USD Source

Cash and cash equivalents: 82.7 thousand USD 2017-06-30 Source
Exact value

82652 USD
Long-term debt including current maturities: 2.63 million USD 2013-12-31 Source
Exact value

2634313 USD
Shares outstanding: 395 million shares 2017-06-30 Source
Exact value

394538316 shares

Reported share-count change

195.05% · 261 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

133720519 shares · 2016-06-30· Source
394538316 shares · 2017-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

2.07 million USD

2016-07-01 – 2017-06-30

Exact inputs and evidence

Revenue: 519908 USD · 2016-07-01 – 2016-09-30 Source
Revenue: 2446795 USD · 2016-01-01 – 2016-12-31 Source
Revenue: 1577010 USD · 2016-01-01 – 2016-09-30 Source
Revenue: 354836 USD · 2017-01-01 – 2017-03-31 Source
Revenue: 328092 USD · 2017-04-01 – 2017-06-30 Source

Net income

-24.1 million USD

2016-07-01 – 2017-06-30

Exact inputs and evidence

Net income: -5518191 USD · 2016-07-01 – 2016-09-30 Source
Net income: -15647922 USD · 2016-01-01 – 2016-12-31 Source
Net income: -8411332 USD · 2016-01-01 – 2016-09-30 Source
Net income: -5864629 USD · 2017-01-01 – 2017-03-31 Source
Net income: -5501348 USD · 2017-04-01 – 2017-06-30 Source

Operating cash flow

-3.66 million USD

2016-07-01 – 2017-06-30

Exact inputs and evidence

Operating cash flow: -3408885 USD · 2016-01-01 – 2016-09-30 Source
Operating cash flow: -2840691 USD · 2016-01-01 – 2016-06-30 Source
Operating cash flow: -4228360 USD · 2016-01-01 – 2016-12-31 Source
Operating cash flow: -3408885 USD · 2016-01-01 – 2016-09-30 Source
Operating cash flow: -834458 USD · 2017-01-01 – 2017-03-31 Source
Operating cash flow: -2270549 USD · 2017-01-01 – 2017-06-30 Source
Operating cash flow: -834458 USD · 2017-01-01 – 2017-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2017-08-29.

Financial data available through: 2016-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2016-12-31
Operating income: 9 of 11 periods available· newest 2016-12-31
Net income: 11 of 11 periods available· newest 2016-12-31
Operating cash flow: 9 of 11 periods available· newest 2016-12-31
capital expenditure: No compatible figures in this window
Total assets: 8 of 11 periods available· newest 2016-12-31
Total liabilities: 1 of 11 periods available· newest 2015-12-31
Current assets: 8 of 11 periods available· newest 2016-12-31
Current liabilities: 8 of 11 periods available· newest 2016-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2016-12-31
Long-term debt including current maturities: 3 of 11 periods available· newest 2013-12-31
Shares outstanding: 8 of 11 periods available· newest 2016-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+31.4%

Prior period

USD 1.86 million

2015-01-01 – 2015-12-31
Current period

USD 2.45 million

2016-01-01 – 2016-12-31

Exact inputs and evidence

2446795 − 1861802 = 584993 USD

1861802 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
2446795 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Protea Biosciences Group, Inc. · 2016-12-31 Protea Biosciences Group, Inc. (edgar:1335103) Year-over-year change in Revenue: 584993 USD Concept: fundies:Revenue Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1335103?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 2446795 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1335103/000114420417020500/prgb-20161231.xml#319098 Filing: 000114420417020500 Input fundies:Revenue: 1861802 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1335103/000114420417020500/prgb-20161231.xml#319239 Filing: 000114420417020500
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 6.07 million

Prior period

−USD 9.57 million

2015-01-01 – 2015-12-31
Current period

−USD 15.65 million

2016-01-01 – 2016-12-31

Exact inputs and evidence

-15647922 − -9574434 = -6073488 USD

-9574434 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
-15647922 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Protea Biosciences Group, Inc. · 2016-12-31 Protea Biosciences Group, Inc. (edgar:1335103) Year-over-year change in Net income: -6073488 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1335103?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -15647922 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1335103/000114420417020500/prgb-20161231.xml#316486 Filing: 000114420417020500 Input fundies:NetIncome: -9574434 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1335103/000114420417020500/prgb-20161231.xml#316625 Filing: 000114420417020500
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 1.34 million

Prior period

−USD 5.56 million

2015-01-01 – 2015-12-31
Current period

−USD 4.23 million

2016-01-01 – 2016-12-31

Exact inputs and evidence

-4228360 − -5564454 = 1336094 USD

-5564454 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
-4228360 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Protea Biosciences Group, Inc. · 2016-12-31 Protea Biosciences Group, Inc. (edgar:1335103) Year-over-year change in Operating cash flow: 1336094 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1335103?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -4228360 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1335103/000114420417020500/prgb-20161231.xml#323321 Filing: 000114420417020500 Input fundies:OperatingCashFlow: -5564454 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1335103/000114420417020500/prgb-20161231.xml#323084 Filing: 000114420417020500
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2016 2016-01-01 – 2016-12-31

Revenue USD 2.45 million 100% of revenue
Cost of revenue USD 1.71 million 70% of revenue
Operating expenses USD 6.23 million 255% of revenue
Operating income −USD 5.49 million −225% of revenue
Tax, interest and other Derived USD 10.15 million 415% of revenue
Net income −USD 15.65 million −640% of revenue

Cash

Operating cash flow −USD 4.23 million −173% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2009 Not shown: operating income or net income is not reported.
2010 Operating loss: operating costs were 2,102% of revenue.
2010 Operating loss: operating costs were 1,122% of revenue.
2011 Operating loss: operating costs were 1,232% of revenue.
2011 Operating loss: operating costs were 1,611% of revenue.
2012 Operating loss: operating costs were 1,176% of revenue.
2013 Operating loss: operating costs were 944% of revenue.
2014 Operating loss: operating costs were 705% of revenue.
2015 Operating loss: operating costs were 484% of revenue.
2016 Operating loss: operating costs were 325% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2009 2009-01-01 – 2009-12-31	0	Unavailable	Unavailable	Unavailable	-5329737	Unavailable	Source 2009-01-01 – 2009-12-31: 0 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -5329737 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -31662 USD Inspect Operating Cash Flow Open source
2010 2009-10-01 – 2010-09-30	131247	2759219 Derived	-2627972	78786 Derived	-2706758	Unavailable	Source 2009-10-01 – 2010-09-30: 131247 USD Inspect Revenue Open source 2009-10-01 – 2010-09-30: -2627972 USD Inspect Operating Income Open source 2009-10-01 – 2010-09-30: -2706758 USD Inspect Net Income Open source
2010 2010-01-01 – 2010-12-31	905467	10156675 Derived	-9251208	332454 Derived	-9583662	Unavailable	Source 2010-01-01 – 2010-12-31: 905467 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -9251208 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -9583662 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -7313171 USD Inspect Operating Cash Flow Open source
2011 2010-10-01 – 2011-09-30	215379	2652948 Derived	-2437569	413513 Derived	-2851082	Unavailable	Source 2010-10-01 – 2011-09-30: 215379 USD Inspect Revenue Open source 2010-10-01 – 2011-09-30: -2437569 USD Inspect Operating Income Open source 2010-10-01 – 2011-09-30: -2851082 USD Inspect Net Income Open source
2011 2011-01-01 – 2011-12-31	713028	11488840 Derived	-10775812	721520 Derived	-11497332	Unavailable	Source 2011-01-01 – 2011-12-31: 713028 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -10775812 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -11497332 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -7967186 USD Inspect Operating Cash Flow Open source
2012 2012-01-01 – 2012-12-31	834250	9814590 Derived	-8980340	550919 Derived	-9531259	Unavailable	Source 2012-01-01 – 2012-12-31: 834250 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -8980340 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -9531259 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -8521997 USD Inspect Operating Cash Flow Open source
2013 2013-01-01 – 2013-12-31	1223492	11548379 Derived	-10324887	1092783 Derived	-11417670	Unavailable	Source 2013-01-01 – 2013-12-31: 1223492 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -10324887 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -11417670 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -10220818 USD Inspect Operating Cash Flow Open source
2014 2014-01-01 – 2014-12-31	1768312	12461460 Derived	-10693148	781622 Derived	-11474770	Unavailable	Source 2014-01-01 – 2014-12-31: 1768312 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -10693148 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -11474770 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -7332813 USD Inspect Operating Cash Flow Open source
2015 2015-01-01 – 2015-12-31	1861802	9001945 Derived	-7140143	2434291 Derived	-9574434	Unavailable	Source 2015-01-01 – 2015-12-31: 1861802 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -7140143 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -9574434 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -5564454 USD Inspect Operating Cash Flow Open source
2016 2016-01-01 – 2016-12-31	2446795	7940014 Derived	-5493219	10154703 Derived	-15647922	Unavailable	Source 2016-01-01 – 2016-12-31: 2446795 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -5493219 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -15647922 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -4228360 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 2.4M 2016

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-12-31	Revenue	0	Revenue: 0 Open source
20102010-09-30	Revenue	131247	Revenue: 131247 Open source
20102010-12-31	Revenue	905467	Revenue: 905467 Open source
20112011-09-30	Revenue	215379	Revenue: 215379 Open source
20112011-12-31	Revenue	713028	Revenue: 713028 Open source
20122012-12-31	Revenue	834250	Revenue: 834250 Open source
20132013-12-31	Revenue	1223492	Revenue: 1223492 Open source
20142014-12-31	Revenue	1768312	Revenue: 1768312 Open source
20152015-12-31	Revenue	1861802	Revenue: 1861802 Open source
20162016-12-31	Revenue	2446795	Revenue: 2446795 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

31.4% 2016

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20102010-09-30	Year over year	No prior comparable period	Revenue: 131247 Open source
20102010-12-31	Year over year	No prior comparable period	Revenue: 905467 Open source Revenue: 0 Open source
20112011-09-30	Year over year	64.1%	Revenue: 215379 Open source Revenue: 131247 Open source
20112011-12-31	Year over year	-21.3%	Revenue: 713028 Open source Revenue: 905467 Open source
20122012-12-31	Year over year	17%	Revenue: 834250 Open source Revenue: 713028 Open source
20132013-12-31	Year over year	46.7%	Revenue: 1223492 Open source Revenue: 834250 Open source
20142014-12-31	Year over year	44.5%	Revenue: 1768312 Open source Revenue: 1223492 Open source
20152015-12-31	Year over year	5.3%	Revenue: 1861802 Open source Revenue: 1768312 Open source
20162016-12-31	Year over year	31.4%	Revenue: 2446795 Open source Revenue: 1861802 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -224.5% 2016

Net margin -639.5% 2016

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2009-12-31	Operating margin	Not reported	Revenue: 0 Open source
20102010-09-30	Operating margin	-2,002.3%	Operating Income: -2627972 Open source Revenue: 131247 Open source
20102010-12-31	Operating margin	-1,021.7%	Operating Income: -9251208 Open source Revenue: 905467 Open source
20112011-09-30	Operating margin	-1,131.8%	Operating Income: -2437569 Open source Revenue: 215379 Open source
20112011-12-31	Operating margin	-1,511.3%	Operating Income: -10775812 Open source Revenue: 713028 Open source
20122012-12-31	Operating margin	-1,076.5%	Operating Income: -8980340 Open source Revenue: 834250 Open source
20132013-12-31	Operating margin	-843.9%	Operating Income: -10324887 Open source Revenue: 1223492 Open source
20142014-12-31	Operating margin	-604.7%	Operating Income: -10693148 Open source Revenue: 1768312 Open source
20152015-12-31	Operating margin	-383.5%	Operating Income: -7140143 Open source Revenue: 1861802 Open source
20162016-12-31	Operating margin	-224.5%	Operating Income: -5493219 Open source Revenue: 2446795 Open source
20092009-12-31	Net margin	Not reported	Net Income: -5329737 Open source Revenue: 0 Open source
20102010-09-30	Net margin	-2,062.3%	Net Income: -2706758 Open source Revenue: 131247 Open source
20102010-12-31	Net margin	-1,058.4%	Net Income: -9583662 Open source Revenue: 905467 Open source
20112011-09-30	Net margin	-1,323.8%	Net Income: -2851082 Open source Revenue: 215379 Open source
20112011-12-31	Net margin	-1,612.5%	Net Income: -11497332 Open source Revenue: 713028 Open source
20122012-12-31	Net margin	-1,142.5%	Net Income: -9531259 Open source Revenue: 834250 Open source
20132013-12-31	Net margin	-933.2%	Net Income: -11417670 Open source Revenue: 1223492 Open source
20142014-12-31	Net margin	-648.9%	Net Income: -11474770 Open source Revenue: 1768312 Open source
20152015-12-31	Net margin	-514.3%	Net Income: -9574434 Open source Revenue: 1861802 Open source
20162016-12-31	Net margin	-639.5%	Net Income: -15647922 Open source Revenue: 2446795 Open source
20092009-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -31662 Open source
20102010-09-30	Free cash flow margin	Not reported	Revenue: 131247 Open source
20102010-12-31	Free cash flow margin	Not reported	Revenue: 905467 Open source Operating Cash Flow: -7313171 Open source
20112011-09-30	Free cash flow margin	Not reported	Revenue: 215379 Open source
20112011-12-31	Free cash flow margin	Not reported	Revenue: 713028 Open source Operating Cash Flow: -7967186 Open source
20122012-12-31	Free cash flow margin	Not reported	Revenue: 834250 Open source Operating Cash Flow: -8521997 Open source
20132013-12-31	Free cash flow margin	Not reported	Revenue: 1223492 Open source Operating Cash Flow: -10220818 Open source
20142014-12-31	Free cash flow margin	Not reported	Revenue: 1768312 Open source Operating Cash Flow: -7332813 Open source
20152015-12-31	Free cash flow margin	Not reported	Revenue: 1861802 Open source Operating Cash Flow: -5564454 Open source
20162016-12-31	Free cash flow margin	Not reported	Revenue: 2446795 Open source Operating Cash Flow: -4228360 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -4.2M 2016

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-12-31	Operating cash flow	-31662	Operating Cash Flow: -31662 Open source
20102010-09-30	Operating cash flow	Not reported	No source recorded
20102010-12-31	Operating cash flow	-7313171	Operating Cash Flow: -7313171 Open source
20112011-09-30	Operating cash flow	Not reported	No source recorded
20112011-12-31	Operating cash flow	-7967186	Operating Cash Flow: -7967186 Open source
20122012-12-31	Operating cash flow	-8521997	Operating Cash Flow: -8521997 Open source
20132013-12-31	Operating cash flow	-10220818	Operating Cash Flow: -10220818 Open source
20142014-12-31	Operating cash flow	-7332813	Operating Cash Flow: -7332813 Open source
20152015-12-31	Operating cash flow	-5564454	Operating Cash Flow: -5564454 Open source
20162016-12-31	Operating cash flow	-4228360	Operating Cash Flow: -4228360 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-12-31	Free cash flow	Unavailable	Operating Cash Flow: -31662 Open source
20102010-09-30	Free cash flow	Unavailable	No source recorded
20102010-12-31	Free cash flow	Unavailable	Operating Cash Flow: -7313171 Open source
20112011-09-30	Free cash flow	Unavailable	No source recorded
20112011-12-31	Free cash flow	Unavailable	Operating Cash Flow: -7967186 Open source
20122012-12-31	Free cash flow	Unavailable	Operating Cash Flow: -8521997 Open source
20132013-12-31	Free cash flow	Unavailable	Operating Cash Flow: -10220818 Open source
20142014-12-31	Free cash flow	Unavailable	Operating Cash Flow: -7332813 Open source
20152015-12-31	Free cash flow	Unavailable	Operating Cash Flow: -5564454 Open source
20162016-12-31	Free cash flow	Unavailable	Operating Cash Flow: -4228360 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

371.8% 2015

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2009-12-31	Liabilities / assets	Not reported	No source recorded
2010-09-30	Liabilities / assets	Not reported	No source recorded
2010-12-31	Liabilities / assets	Not reported	Total Assets: 4598100 Open source
2011-09-30	Liabilities / assets	Not reported	Total Assets: 5249738 Open source
2011-12-31	Liabilities / assets	Not reported	Total Assets: 4649073 Open source
2012-12-31	Liabilities / assets	Not reported	Total Assets: 4212031 Open source
2013-12-31	Liabilities / assets	Not reported	Total Assets: 5417927 Open source
2014-12-31	Liabilities / assets	Not reported	Total Assets: 4028127 Open source
20152015-12-31	Liabilities / assets	371.8%	Total Liabilities: 11316328 Open source Total Assets: 3043746 Open source
2016-12-31	Liabilities / assets	Not reported	Total Assets: 3214090 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.05× 2016

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2009-12-31	Current assets / current liabilities	Not reported	No source recorded
2010-09-30	Current assets / current liabilities	Not reported	No source recorded
20102010-12-31	Current assets / current liabilities	0.25×	Current Assets: 1502174 Open source Current Liabilities: 5965979 Open source
20112011-09-30	Current assets / current liabilities	0.41×	Current Assets: 2139942 Open source Current Liabilities: 5184382 Open source
20112011-12-31	Current assets / current liabilities	0.19×	Current Assets: 1312222 Open source Current Liabilities: 6963401 Open source
20122012-12-31	Current assets / current liabilities	0.14×	Current Assets: 1399012 Open source Current Liabilities: 10032836 Open source
20132013-12-31	Current assets / current liabilities	0.37×	Current Assets: 2508502 Open source Current Liabilities: 6848692 Open source
20142014-12-31	Current assets / current liabilities	0.12×	Current Assets: 931344 Open source Current Liabilities: 7765562 Open source
20152015-12-31	Current assets / current liabilities	0.04×	Current Assets: 411591 Open source Current Liabilities: 9590170 Open source
20162016-12-31	Current assets / current liabilities	0.05×	Current Assets: 728924 Open source Current Liabilities: 15550489 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2009 2009-01-01 – 2009-12-31	−USD 5.33 million Exact value Exact value: -5329737 USD 2009-01-01 – 2009-12-31: -5329737 USD Inspect Net Income Open source Share or cite Citation for Net Income · Protea Biosciences Group, Inc. · 2009-12-31 Protea Biosciences Group, Inc. (edgar:1335103) Net Income: -5329737 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1335103/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5329737 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1335103/000114420414018911/ptbg-20131231.xml#1553054 Filing: 000114420414018911 The citation records this snapshot. The page link may show a newer release later.	−USD 31,662 Exact value Exact value: -31662 USD 2009-01-01 – 2009-12-31: -31662 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Protea Biosciences Group, Inc. · 2009-12-31 Protea Biosciences Group, Inc. (edgar:1335103) Operating Cash Flow: -31662 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1335103/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31662 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1335103/0001144204-11-010387.txt#3209 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2010 2009-10-01 – 2010-09-30	−USD 2.71 million Exact value Exact value: -2706758 USD 2009-10-01 – 2010-09-30: -2706758 USD Inspect Net Income Open source Share or cite Citation for Net Income · Protea Biosciences Group, Inc. · 2010-09-30 Protea Biosciences Group, Inc. (edgar:1335103) Net Income: -2706758 USD Concept: fundies:NetIncome Period: 2009-10-01 to 2010-09-30 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1335103/explain?concept=fundies%3ANetIncome&period=2010-09-30&surface=latest&period_type=duration&start=2009-10-01&unit=USD&dimensions= Input fundies:NetIncome: -2706758 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1335103/0001144204-11-064585.txt#1574 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2010 2010-01-01 – 2010-12-31	−USD 9.58 million Exact value Exact value: -9583662 USD 2010-01-01 – 2010-12-31: -9583662 USD Inspect Net Income Open source Share or cite Citation for Net Income · Protea Biosciences Group, Inc. · 2010-12-31 Protea Biosciences Group, Inc. (edgar:1335103) Net Income: -9583662 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1335103/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9583662 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1335103/000114420414018911/ptbg-20131231.xml#1554188 Filing: 000114420414018911 The citation records this snapshot. The page link may show a newer release later.	−USD 7.31 million Exact value Exact value: -7313171 USD 2010-01-01 – 2010-12-31: -7313171 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Protea Biosciences Group, Inc. · 2010-12-31 Protea Biosciences Group, Inc. (edgar:1335103) Operating Cash Flow: -7313171 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1335103/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7313171 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1335103/000114420412018104/ptbg-20111231.xml#119205 Filing: 000114420412018104 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2011 2010-10-01 – 2011-09-30	−USD 2.85 million Exact value Exact value: -2851082 USD 2010-10-01 – 2011-09-30: -2851082 USD Inspect Net Income Open source Share or cite Citation for Net Income · Protea Biosciences Group, Inc. · 2011-09-30 Protea Biosciences Group, Inc. (edgar:1335103) Net Income: -2851082 USD Concept: fundies:NetIncome Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1335103/explain?concept=fundies%3ANetIncome&period=2011-09-30&surface=latest&period_type=duration&start=2010-10-01&unit=USD&dimensions= Input fundies:NetIncome: -2851082 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1335103/0001144204-11-064585.txt#1574 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2011 2011-01-01 – 2011-12-31	−USD 11.5 million Exact value Exact value: -11497332 USD 2011-01-01 – 2011-12-31: -11497332 USD Inspect Net Income Open source Share or cite Citation for Net Income · Protea Biosciences Group, Inc. · 2011-12-31 Protea Biosciences Group, Inc. (edgar:1335103) Net Income: -11497332 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1335103/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11497332 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1335103/000114420414018911/ptbg-20131231.xml#1555322 Filing: 000114420414018911 The citation records this snapshot. The page link may show a newer release later.	−USD 7.97 million Exact value Exact value: -7967186 USD 2011-01-01 – 2011-12-31: -7967186 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Protea Biosciences Group, Inc. · 2011-12-31 Protea Biosciences Group, Inc. (edgar:1335103) Operating Cash Flow: -7967186 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1335103/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7967186 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1335103/000114420413017920/ptbg-20121231.xml#328358 Filing: 000114420413017920 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2012 2012-01-01 – 2012-12-31	−USD 9.53 million Exact value Exact value: -9531259 USD 2012-01-01 – 2012-12-31: -9531259 USD Inspect Net Income Open source Share or cite Citation for Net Income · Protea Biosciences Group, Inc. · 2012-12-31 Protea Biosciences Group, Inc. (edgar:1335103) Net Income: -9531259 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1335103/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9531259 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1335103/000114420414018911/ptbg-20131231.xml#1328182 Filing: 000114420414018911 The citation records this snapshot. The page link may show a newer release later.	−USD 8.52 million Exact value Exact value: -8521997 USD 2012-01-01 – 2012-12-31: -8521997 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Protea Biosciences Group, Inc. · 2012-12-31 Protea Biosciences Group, Inc. (edgar:1335103) Operating Cash Flow: -8521997 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1335103/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8521997 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1335103/000114420414018911/ptbg-20131231.xml#1616150 Filing: 000114420414018911 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2013 2013-01-01 – 2013-12-31	−USD 11.42 million Exact value Exact value: -11417670 USD 2013-01-01 – 2013-12-31: -11417670 USD Inspect Net Income Open source Share or cite Citation for Net Income · Protea Biosciences Group, Inc. · 2013-12-31 Protea Biosciences Group, Inc. (edgar:1335103) Net Income: -11417670 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1335103/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11417670 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1335103/000114420415009195/prgb-20141231.xml#1163549 Filing: 000114420415009195 The citation records this snapshot. The page link may show a newer release later.	−USD 10.22 million Exact value Exact value: -10220818 USD 2013-01-01 – 2013-12-31: -10220818 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Protea Biosciences Group, Inc. · 2013-12-31 Protea Biosciences Group, Inc. (edgar:1335103) Operating Cash Flow: -10220818 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1335103/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10220818 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1335103/000114420415009195/prgb-20141231.xml#1312594 Filing: 000114420415009195 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2014 2014-01-01 – 2014-12-31	−USD 11.47 million Exact value Exact value: -11474770 USD 2014-01-01 – 2014-12-31: -11474770 USD Inspect Net Income Open source Share or cite Citation for Net Income · Protea Biosciences Group, Inc. · 2014-12-31 Protea Biosciences Group, Inc. (edgar:1335103) Net Income: -11474770 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1335103/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11474770 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1335103/000114420416105381/prgb-20160331.xml#266777 Filing: 000114420416105381 The citation records this snapshot. The page link may show a newer release later.	−USD 7.33 million Exact value Exact value: -7332813 USD 2014-01-01 – 2014-12-31: -7332813 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Protea Biosciences Group, Inc. · 2014-12-31 Protea Biosciences Group, Inc. (edgar:1335103) Operating Cash Flow: -7332813 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1335103/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7332813 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1335103/000114420416105381/prgb-20160331.xml#1667198 Filing: 000114420416105381 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2015 2015-01-01 – 2015-12-31	−USD 9.57 million Exact value Exact value: -9574434 USD 2015-01-01 – 2015-12-31: -9574434 USD Inspect Net Income Open source Share or cite Citation for Net Income · Protea Biosciences Group, Inc. · 2015-12-31 Protea Biosciences Group, Inc. (edgar:1335103) Net Income: -9574434 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1335103/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9574434 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1335103/000114420417020500/prgb-20161231.xml#316625 Filing: 000114420417020500 The citation records this snapshot. The page link may show a newer release later.	−USD 5.56 million Exact value Exact value: -5564454 USD 2015-01-01 – 2015-12-31: -5564454 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Protea Biosciences Group, Inc. · 2015-12-31 Protea Biosciences Group, Inc. (edgar:1335103) Operating Cash Flow: -5564454 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1335103/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5564454 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1335103/000114420417020500/prgb-20161231.xml#323084 Filing: 000114420417020500 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2016-01-01 – 2016-12-31	−USD 15.65 million Exact value Exact value: -15647922 USD 2016-01-01 – 2016-12-31: -15647922 USD Inspect Net Income Open source Share or cite Citation for Net Income · Protea Biosciences Group, Inc. · 2016-12-31 Protea Biosciences Group, Inc. (edgar:1335103) Net Income: -15647922 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1335103/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15647922 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1335103/000114420417020500/prgb-20161231.xml#316486 Filing: 000114420417020500 The citation records this snapshot. The page link may show a newer release later.	−USD 4.23 million Exact value Exact value: -4228360 USD 2016-01-01 – 2016-12-31: -4228360 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Protea Biosciences Group, Inc. · 2016-12-31 Protea Biosciences Group, Inc. (edgar:1335103) Operating Cash Flow: -4228360 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1335103/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4228360 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1335103/000114420417020500/prgb-20161231.xml#323321 Filing: 000114420417020500 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

56 filings · 2,680 latest values · 2,670 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001335103, 1335103, PRGB, PTBG, edgar:1335103, ptbg, srkp

Also known as Protea Biosciences Group, Inc., Protea Biosciences Inc., SRKP 5 INC

Protea Biosciences Group, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2016 2016-01-01 – 2016-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation